Northwest Bioth New (NWBO) Stock Price & Overview

NASDAQ:NWBO

Current stock price

0.57
-0.13 (-18.57%)
At close:
0.53
-0.04 (-7.02%)
After Hours:

The current stock price of NWBO is 0.57 null. Today NWBO is down by -18.57%. In the past month the price increased by 1.79%. In the past year, price decreased by -87.02%.

NWBO Key Statistics

52-Week Range0.32 - 4.66
Current NWBO stock price positioned within its 52-week range.
1-Month Range0.34 - 0.98
Current NWBO stock price positioned within its 1-month range.
Market Cap
109.326M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.77
Dividend Yield
N/A

NWBO Stock Performance

Today
-18.57%
1 Week
-5.00%
1 Month
+1.79%
3 Months
+21.28%
Longer-term
6 Months -8.06%
1 Year -87.02%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

NWBO Stock Chart

Northwest Bioth New / NWBO Daily stock chart

NWBO Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to NWBO. When comparing the yearly performance of all stocks, NWBO is a bad performer in the overall market: 91.35% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NWBO Earnings

On null NWBO reported an EPS of -0.02 and a revenue of 230.00K.

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ4 / 2024
EPS Reported-$0.02
Revenue Reported230K
EPS Surprise %
Revenue Surprise %

NWBO Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

NWBO Financial Highlights

Over the last trailing twelve months NWBO reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS increased by 32.95% compared to the year before.


Income Statements
Revenue(TTM)1.42M
Net Income(TTM)N/A
Industry RankSector Rank
PM (TTM) 100.73%
ROA -168.29%
ROE 0%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)32.95%
Revenue 1Y (TTM)N/A

NWBO Ownership

Ownership
Inst Owners0.33%
Shares191.80M
Float143.85M
Ins Owners45.13%
Short Float %41.17%
Short Ratio31.02

About NWBO

Company Profile

Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.

Company Info

Northwest Bioth New

4800 MONTGOMERY LANE SUITE 800

BETHESDA MD 20814

CEO: Linda F. Powers

Phone: 240-497-9024

Northwest Bioth New / NWBO FAQ

Can you describe the business of Northwest Bioth New?

Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.


What is the current price of NWBO stock?

The current stock price of NWBO is 0.57 null. The price decreased by -18.57% in the last trading session.


Does NWBO stock pay dividends?

NWBO does not pay a dividend.


What is the ChartMill rating of Northwest Bioth New stock?

NWBO has a ChartMill Technical rating of 5 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.


Where is Northwest Bioth New (NWBO) stock traded?

NWBO stock is listed on the Nasdaq exchange.


Can you provide the ownership details for NWBO stock?

You can find the ownership structure of Northwest Bioth New (NWBO) on the Ownership tab.